Match!

Current Concepts of Neurodegenerative Mechanisms in Alzheimer’s Disease

Published on Jan 1, 2018in BioMed Research International2.197
· DOI :10.1155/2018/3740461
Kasthuri Bai Magalingam6
Estimated H-index: 6
(Nilai University),
Ammu Kutty Radhakrishnan21
Estimated H-index: 21
(International Medical University)
+ 1 AuthorsNagaraja Haleagrahara17
Estimated H-index: 17
(JCU: James Cook University)
Abstract
Neurodegenerative diseases are hereditary or sporadic conditions that result in the progressive loss of the structure and function of neurons as well as neuronal death. Although a range of diseases lie under this umbrella term, Alzheimer’s disease (AD) and Parkinson’s disease (PD) are the most common neurodegenerative diseases that affect a large population around the globe. Alzheimer’s disease is characterized by the abnormal accumulation of extracellular amyloid-β plaques and intraneuronal neurofibrillary tangles in brain regions and manifests as a type of dementia in aged individuals that results in memory loss, multiple cognitive abnormalities, and intellectual disabilities that interfere with quality of life. Since the discovery of AD, a wealth of new information has emerged that delineates the causes, mechanisms of disease, and potential therapeutic agents, but an effective remedy to cure the diseases has not been identified yet. This could be because of the complexity of the disease process, as it involves various contributing factors that include environmental factors and genetic predispositions. This review summarizes the current understanding on neurodegenerative mechanisms that lead to the emergence of the pathology of AD.
  • References (71)
  • Citations (15)
📖 Papers frequently viewed together
1 Citations
17 Citations
2012
4 Authors (YoungSoo Kim, ..., Dong Jin Kim)
5 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
References71
Newest
#1Yuki Ozaki (Ehime University)H-Index: 7
#2Yuta Yoshino (Ehime University)H-Index: 7
Last. Shu-ichi Ueno (Ehime University)H-Index: 32
view all 10 authors...
Abstract Objectives Recent genome-wide association studies revealed that Triggering receptor expressed on myeloid cells 2 ( TREM2 ) was associated with Alzheimer's disease (AD) and other neurodegenerative diseases. We previously reported that TREM2 mRNA is highly expressed in leukocytes of AD patients compared to those in healthy controls. However, the mechanism of TREM2 expression change is still not known. In this study, we examined the involvement of the DNA methylation status of TREM2 in its...
16 CitationsSource
#1Benjamin Combs (MSU: Michigan State University)H-Index: 9
#2Chelsey Hamel (MSU: Michigan State University)H-Index: 2
Last. Nicholas M. Kanaan (MSU: Michigan State University)H-Index: 26
view all 3 authors...
Abstract Conformational changes involving the amino terminus of the tau protein are among the earliest alterations associated with tau pathology in Alzheimer's disease and other tauopathies. This region of tau contains a phosphatase-activating domain (PAD) that is aberrantly exposed in pathological forms of the protein, an event that is associated with disruptions in anterograde fast axonal transport. We utilized four antibodies that recognize the amino terminus of tau, TNT1, TNT2 (a novel antib...
22 CitationsSource
#1Sandro Dá Mesquita (RMIT: RMIT University)H-Index: 7
#2Ana Catarina Ferreira (RMIT: RMIT University)H-Index: 9
Last. Fernanda Marques (RMIT: RMIT University)H-Index: 27
view all 6 authors...
Abstract Alzheimer's disease (AD) is the most common form of dementia, whose prevalence is growing along with the increased life expectancy. Although the accumulation and deposition of amyloid beta (Aβ) peptides in the brain is viewed as one of the pathological hallmarks of AD and underlies, at least in part, brain cell dysfunction and behavior alterations, the etiology of this neurodegenerative disease is still poorly understood. Noticeably, increased amyloid load is accompanied by marked infla...
47 CitationsSource
The cellular quality control system degrades abnormal or misfolded proteins and consists of three different mechanisms: the ubiquitin proteasomal system (UPS), autophagy and molecular chaperones. Any disturbance in this system causes proteins to accumulate, resulting in neurodegenerative diseases such as amyotrophic lateral sclerosis, Alzheimer's disease (AD), Parkinson's disease, Huntington's disease and prion or polyglutamine diseases. Alzheimer's disease is currently one of the most common ag...
38 CitationsSource
#1Lih-Fen LueH-Index: 43
Last. Douglas G. WalkerH-Index: 63
view all 6 authors...
Triggering receptor expressed by myeloid cells 2 (TREM2), a member of the immunoglobulin superfamily, has anti-inflammatory phagocytic function in myeloid cells. Several studies have shown that TREM2 gene variant rs75932628-T increased the risks for Alzheimer's disease (AD), Parkinson's disease, frontotemporal dementia and amyotrophic lateral sclerosis. It has been suggested that the risks could be resulted from the loss of TREM2 function caused by the mutation. Indeed, new evidence showed that ...
66 CitationsSource
#1Andrea Di Francesco (University of Teramo)H-Index: 15
#2Beatrice Arosio (University of Milan)H-Index: 25
Last. Claudio D'Addario (University of Teramo)H-Index: 21
view all 9 authors...
Changes in epigenetic marks may help explain the late onset of Alzheimer’s disease (AD). In this study we measured genome-wide DNA methylation by luminometric methylation assay, a quantitative measurement of genome-wide DNA methylation, on DNA isolated from peripheral blood mononuclear cells of 37 subjects with late-onset AD (LOAD) and 44 healthy controls (CT). We found an increase in global DNA methylation in LOAD subjects compared to CT (p = 0.0122), associated with worse cognitive performance...
48 CitationsSource
#1Elizabeta GjoneskaH-Index: 7
#2Andreas R. PfenningH-Index: 14
Last. Manolis KamvysselisH-Index: 94
view all 7 authors...
Analysis of transcriptional and epigenomic changes in the hippocampus of a mouse model of Alzheimer’s disease shows that immune function genes and regulatory regions are upregulated, whereas genes and regulatory regions involved in synaptic plasticity, learning and memory are downregulated; genetic variants associated with Alzheimer’s disease are only enriched in orthologues of upregulated immune regions, suggesting that dysregulation of immune processes may underlie Alzheimer’s disease predispo...
263 CitationsSource
#1Pritika Narayan (University of Auckland)H-Index: 12
#2Claire L. Lill (University of Auckland)H-Index: 7
Last. Michael Dragunow (University of Auckland)H-Index: 78
view all 5 authors...
Abstract Histone acetylation is an epigenetic modification that plays a critical role in chromatin remodelling and transcriptional regulation. There is increasing evidence that epigenetic modifications may become compromised in aging and increase susceptibility to the development of neurodegenerative disorders such as Alzheimer's disease. Immunohistochemical labelling of free-floating sections from the inferior temporal gyrus (Alzheimer's disease, n = 14; control, n = 17) and paraffin-embedded t...
50 CitationsSource
#1Shu-ichi Okamoto (Sanford-Burnham Institute for Medical Research)H-Index: 14
#2Tomohiro Nakamura (Sanford-Burnham Institute for Medical Research)H-Index: 26
Last. Stuart A. Lipton (Sanford-Burnham Institute for Medical Research)H-Index: 123
view all 26 authors...
Summary Redox-mediated posttranslational modifications represent a molecular switch that controls major mechanisms of cell function. Nitric oxide (NO) can mediate redox reactions via S-nitrosylation, representing transfer of an NO group to a critical protein thiol. NO is known to modulate neurogenesis and neuronal survival in various brain regions in disparate neurodegenerative conditions. However, a unifying molecular mechanism linking these phenomena remains unknown. Here, we report that S-nit...
34 CitationsSource
#1Natacha Coppieters (University of Auckland)H-Index: 5
#2Birger Dieriks (University of Auckland)H-Index: 10
Last. Michael Dragunow (University of Auckland)H-Index: 78
view all 6 authors...
Abstract DNA methylation (5-methylcytosine [5mC]) is one of several epigenetic markers altered in Alzheimer's disease (AD) brain. More recently, attention has been given to DNA hydroxymethylation (5-hydroxymethylcytosine [5hmC]), the oxidized form of 5mC. Whereas 5mC is generally associated with the inhibition of gene expression, 5hmC has been associated with increased gene expression and is involved in cellular processes such as differentiation, development, and aging. Recent findings point tow...
176 CitationsSource
Cited By15
Newest
#1Richard Seager (UoB: University of Bristol)
#2Laura L. Lee (UoB: University of Bristol)H-Index: 8
Last. Kevin A. Wilkinson (UoB: University of Bristol)H-Index: 18
view all 4 authors...
Source
#2Cristina Chircov (Politehnica University of Bucharest)H-Index: 4
Last. Alexandru Mihai Grumezescu (Politehnica University of Bucharest)H-Index: 24
view all 3 authors...
While terrestrial organisms are the primary source of natural products, recent years have witnessed a considerable shift towards marine-sourced biocompounds. They have achieved a great scientific interest due to the plethora of compounds with structural and chemical properties generally not found in terrestrial products, exhibiting significant bioactivity ten times higher than terrestrial-sourced molecules. In addition to the antioxidant, anti-thrombotic, anti-coagulant, anti-inflammatory, anti-...
Source
#1Zhengyu Li (NCU: Nanchang University)H-Index: 1
#2Li Gan (NCU: Nanchang University)H-Index: 1
Last. Wei Huang (NCU: Nanchang University)H-Index: 1
view all 5 authors...
Source
Neurodegenerative diseases include a variety of pathologies such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, amyotrophic lateral sclerosis, and so forth, which share many common characteristics such as oxidative stress, glycation, abnormal protein deposition, inflammation, and progressive neuronal loss. The last century has witnessed significant research to identify mechanisms and risk factors contributing to the complex etiopathogenesis of neurodegenerative diseases, such...
1 CitationsSource
#1Saima ZameerH-Index: 4
#2Mahtab AlamH-Index: 1
Last. Mohd Akhtar (Jamia Hamdard)H-Index: 14
view all 6 authors...
Abstract Obesity and consumption of diet rich in fat are known to contribute to the development of Alzheimer’s disease (AD) which is a complex and multifactorial neurodegenerative disease and a leading cause of mortality with unmet medical needs. Hypercholesterolemia was discovered to increase neuropathological changes alongwith cognitive decline in AD mouse models but still the underlying mechanism is elusive. Furthermore, isoprenoids, the crucial products of Mevalonate-pathway produced by the ...
Source
#1Mehdi Sharifi-Rad (KMU: Kerman Medical University)H-Index: 18
#2Chintha Lankatillake (RMIT: RMIT University)H-Index: 1
Last. Ana MoreiraH-Index: 1
view all 16 authors...
Among the major neurodegenerative disorders (NDDs), Alzheimer's disease (AD) and Parkinson's disease (PD), are a huge socioeconomic burden. Over many centuries, people have sought a cure for NDDs from the natural herbals. Many medicinal plants and their secondary metabolites are reported with the ability to alleviate the symptoms of NDDs. The major mechanisms identified, through which phytochemicals exert their neuroprotective effects and potential maintenance of neurological health in ageing, i...
Source
#1Lorenza BellusciH-Index: 3
Last. Nicola OrigliaH-Index: 19
view all 12 authors...
3-iodothyronamine (T1AM) and the recently developed analog SG-2 are rapidly emerging as promising multi-target neuroprotective ligands able to reprogram lipid metabolism and to produce memory enhancement in mice. To elucidate the molecular mechanisms underlying the multi-target effects of these novel drug candidates, here we investigated whether the modulation of SIRT6, known to play a key role in reprogramming energy metabolism, might also drive the activation of clearing pathways, such as auto...
1 CitationsSource
#1Shahul Hameed (NUS: National University of Singapore)H-Index: 4
#2Jong-Ling Fuh (NYMU: National Yang-Ming University)H-Index: 54
Last. Oliver Simon (Novartis)
view all 9 authors...
Clinical diagnosis of Alzheimer's disease (AD) is based on symptoms; however, the challenge is to diagnose AD at the preclinical stage with the application of biomarkers and initiate early treatment (still not widely available). Currently, cerebrospinal fluid (CSF) amyloid-beta 42 (Abeta42) and tau are used in the clinical diagnosis of AD; nevertheless, blood biomarkers (Abeta42 and tau) are less predictive. Amyloid-positron emission tomography (PET) imaging is an advancement in technology that ...
Source
#1Michael Harper (UCSF: University of California, San Francisco)H-Index: 5
#1Michael Harper (UC: University of California)
Last. Anne M. Suskind (UC: University of California)
view all 2 authors...
Dementia is not a single disease, but instead represents a progressive loss of ability in more than one domain of cognition severe enough to result in decline in an individual’s ability to perform daily activities. Urinary incontinence, along with other lower urinary tract symptoms and conditions, is common among older adults with dementia and may result from either functional incontinence or from other conditions related to both aging and disease process itself. Management of lower urinary trac...
Source
#1Elizabeth A. Thomas (Scripps Research Institute)H-Index: 40
A major drawback for biomarker research on neurodegenerative diseases is that the pathologically affected tissue, i.e., the brain, cannot easily be accessed for sampling or biopsy. Hence, researchers have turned to peripheral tissues as biospecimens for such studies. The most commonly used biofluid is blood (serum or plasma), although urine and sweat have also been studied. This chapter will focus on the use of saliva as a biofluid for biomarker research studies on neurodegenerative diseases. Sa...
Source